A New RNA-Dependent Cas12g Nuclease

Area of Science:

• Molecular Biology
• Biotechnology
• Genetics

Background:

• RNA-targeting CRISPR-Cas systems are advancing gene editing and regulation.
• RNA editing offers a reversible alternative to genome editing, mitigating risks of permanent mutations.
• Applications include treating genetic disorders caused by RNA mutations.

Purpose of the Study:

• To investigate a novel Cas12g nuclease identified in thermophilic microbial communities.
• To characterize the enzymatic activities and potential applications of this new CRISPR-Cas effector.
• To contribute to the understanding of CRISPR-Cas systems and their diverse functionalities.

Main Methods:

• Metagenomic analysis to identify novel nucleases.
• In vitro RNA cleavage experiments to assess enzymatic activity.
• Characterization of cis-cleavage activity for the Cas12g effector.

Main Results:

• A previously undescribed Cas12g nuclease was identified from thermophilic microbial metagenomes.
• In vitro experiments confirmed the cis-cleavage activity of this type V-G Cas effector.
• The study provides a method applicable to other Cas orthologs and variants.

Conclusions:

• The discovery of Cas12g expands the toolkit for RNA targeting and gene regulation.
• This nuclease holds potential for developing novel therapeutic strategies for RNA-based genetic disorders.
• Further research into CRISPR-Cas systems will accelerate advancements in genome editing and biotechnology.